IRWDIronwood Pharmaceuticals, Inc.

$603M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$131M+38.7% YoY

Gross Profit

$109M83.6% margin

Operating Income

$6M4.6% margin

Net Income

-$15M-11.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+99.0%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$6M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$332M

Total Liabilities

$528M

Stockholders' Equity

-$196M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131M	$94M	+38.7%
Gross Profit	$109M	$85M	+28.4%
Operating Income	$6M	$23M	-73.7%
Net Income	-$15M	$12M	-228.2%

Revenue Segments

Active Pharmaceutical Ingredient

$46M99%

Product

$479,0001%

Geographic Segments

J

$46M100%

IRWD Q4 2018 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena